MGIT-seq for the Identification of Nontuberculous Mycobacteria and Drug Resistance: a Prospective Study.
macrolide resistance
multilocus sequence typing
nontuberculous mycobacteria
Journal
Journal of clinical microbiology
ISSN: 1098-660X
Titre abrégé: J Clin Microbiol
Pays: United States
ID NLM: 7505564
Informations de publication
Date de publication:
20 04 2023
20 04 2023
Historique:
medline:
24
4
2023
pubmed:
23
3
2023
entrez:
22
3
2023
Statut:
ppublish
Résumé
Because nontuberculous mycobacterial pulmonary disease is a considerable health burden, a simple and clinically applicable analytical protocol enabling the identification of subspecies and drug-resistant disease is required to determine the treatment strategy. We aimed to develop a simplified workflow consisting only of direct sequencing of mycobacterial growth indicator tube cultures (MGIT-seq). In total, 138 patients were prospectively enrolled between April 2021 and May 2022, and culture-positive MGIT broths were subjected to sequencing using MinION, a portable next-generation sequencer. Sequence analysis was conducted to identify species using core genome multilocus sequence typing and to predict macrolide and amikacin (AMK) resistance based on previously reported mutations in
Identifiants
pubmed: 36946719
doi: 10.1128/jcm.01626-22
pmc: PMC10117113
doi:
Substances chimiques
Anti-Bacterial Agents
0
Amikacin
84319SGC3C
Macrolides
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0162622Références
Antimicrob Agents Chemother. 2016 Oct 21;60(11):6758-6765
pubmed: 27572413
Clin Microbiol Infect. 2018 Jun;24(6):599-603
pubmed: 29174730
Sci Rep. 2022 Jan 24;12(1):1237
pubmed: 35075208
J Clin Microbiol. 2022 Sep 21;60(9):e0021722
pubmed: 35969171
Ann Am Thorac Soc. 2016 Nov;13(11):1904-1911
pubmed: 27513168
Eur Respir J. 2020 Jan 2;55(1):
pubmed: 31558660
Antimicrob Agents Chemother. 2015 Nov;59(11):7153-5
pubmed: 26324275
Thorac Surg Clin. 2019 Feb;29(1):65-76
pubmed: 30454923
J Clin Microbiol. 2016 Jun;54(6):1653-1655
pubmed: 27030487
Ann Am Thorac Soc. 2014 Jan;11(1):1-8
pubmed: 24102151
Emerg Microbes Infect. 2019;8(1):1043-1053
pubmed: 31287781
Front Cell Infect Microbiol. 2020 Sep 01;10:449
pubmed: 32984073
J Mass Spectrom. 2017 Sep;52(9):597-602
pubmed: 28480547
Emerg Infect Dis. 2017 Mar;23(3):439-447
pubmed: 28221128
Sci Rep. 2019 Dec 27;9(1):20216
pubmed: 31882826
BMC Infect Dis. 2020 Nov 25;20(1):888
pubmed: 33238934
J Clin Microbiol. 2016 Jul;54(7):1915-1917
pubmed: 27147723
J Antimicrob Chemother. 2012 Apr;67(4):810-8
pubmed: 22290346
J Clin Microbiol. 2017 Feb;55(2):624-634
pubmed: 28003422
Int J Syst Evol Microbiol. 2021 May;71(5):
pubmed: 33974531
Antimicrob Agents Chemother. 2018 Mar 27;62(4):
pubmed: 29378709
J Clin Microbiol. 2017 May;55(5):1285-1298
pubmed: 28275074
Infect Genet Evol. 2019 Aug;72:169-182
pubmed: 30315892
J Clin Microbiol. 2020 Dec 17;59(1):
pubmed: 33055186
Genome Biol. 2016 Nov 25;17(1):239
pubmed: 27887629
Lancet Respir Med. 2016 Jan;4(1):49-58
pubmed: 26669893
Emerg Infect Dis. 2016 Jun;22(6):1116-7
pubmed: 27191735
Front Microbiol. 2018 Feb 13;9:67
pubmed: 29497402
Eur Respir J. 2020 Jul 7;56(1):
pubmed: 32636299
Microbiol Spectr. 2021 Dec 22;9(3):e0061021
pubmed: 34817282
Sci Rep. 2021 Jan 13;11(1):1178
pubmed: 33441977
Eur Respir J. 2021 Jan 5;57(1):
pubmed: 32764113
Microbiol Resour Announc. 2022 Jun 16;11(6):e0007822
pubmed: 35532535
Int J Syst Evol Microbiol. 2014 Jan;64(Pt 1):39-45
pubmed: 24006480
Eur Respir J. 2020 Jan 2;55(1):
pubmed: 31619468
EBioMedicine. 2021 Feb;64:103187
pubmed: 33446475
J Microbiol Methods. 2008 Sep;75(1):1-11
pubmed: 18599139
Am J Respir Crit Care Med. 2018 Dec 15;198(12):1559-1569
pubmed: 30216086
Int J Tuberc Lung Dis. 2016 May;20(5):582-7
pubmed: 27084809
J Clin Microbiol. 2018 Jan 24;56(2):
pubmed: 29167290
J Antimicrob Chemother. 2014 Jun;69(6):1559-63
pubmed: 24500188
Kekkaku. 2016 Oct;91(10):623-629
pubmed: 30646447
Sci Rep. 2017 Mar 27;7:45258
pubmed: 28345639
Int J Tuberc Lung Dis. 2003 Jun;7(6):569-74
pubmed: 12797700
Semin Respir Crit Care Med. 2018 Jun;39(3):351-361
pubmed: 30071550
Am J Respir Crit Care Med. 2010 Mar 1;181(5):514-21
pubmed: 20007929
J Antimicrob Chemother. 2011 Apr;66(4):722-9
pubmed: 21393190
J Clin Microbiol. 2013 Oct;51(10):3389-94
pubmed: 23946523
Eur Respir J. 2021 Mar 18;57(3):
pubmed: 32943401
BMC Infect Dis. 2016 Jan 27;16:31
pubmed: 26818764
Int J Syst Evol Microbiol. 2018 Jan;68(1):461-466
pubmed: 29292687
Tuberculosis (Edinb). 2021 Mar;127:102051
pubmed: 33450448
Am J Respir Crit Care Med. 2006 Oct 15;174(8):928-34
pubmed: 16858014
Respir Res. 2020 Jun 16;21(1):153
pubmed: 32546152
Future Microbiol. 2014;9(9):1095-110
pubmed: 25340838
Am J Clin Pathol. 2014 Jan;141(1):25-34
pubmed: 24343734
Front Cell Infect Microbiol. 2022 Mar 28;12:816615
pubmed: 35419298
Ann Am Thorac Soc. 2019 Mar;16(3):341-347
pubmed: 30339468
J Clin Microbiol. 2018 Jul 26;56(8):
pubmed: 29848567
Sci Rep. 2018 Mar 7;8(1):4131
pubmed: 29515167
J Clin Microbiol. 2019 Jul 26;57(8):
pubmed: 31167842
J Clin Microbiol. 2017 Jul;55(7):2045-2054
pubmed: 28424252
Clin Microbiol Infect. 2018 Apr;24(4):409-413
pubmed: 28782649